{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:00:15Z","timestamp":1790787615569,"version":"4.1.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>The mortality of pulmonary embolism in children is high, and there is no standardized treatment protocol. We present a case of successful treatment of <jats:italic>Mycoplasma pneumoniae<\/jats:italic> (<jats:italic>M pneumoniae<\/jats:italic>) with pulmonary embolism in a child using rivaroxaban and doxycycline, thereby exploring a more appropriate treatment option. A 10-year-old male presented with fever, cough, and chest pain as the main symptoms. <jats:italic>M pneumoniae<\/jats:italic> polymerase chain reaction of bronchoalveolar lavage fluid was positive, and computed tomography angiography indicated pulmonary embolism. Azithromycin, doxycycline, and piperacillin-tazobactam were administered sequentially for infection control, while methylprednisolone was given to control inflammation and heparin and rivaroxaban for sequential treatment, resulting in a satisfactory recovery.<\/jats:p>","DOI":"10.3389\/fped.2025.1449493","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T07:28:06Z","timestamp":1739345286000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Successful rivaroxaban and doxycycline therapy for Mycoplasma pneumonia with pulmonary embolism in children: a case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Fang","family":"Xiaoqian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Hemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jpeds.2004.06.021","article-title":"Incidence of venous thromboembolism in infants and children: data from the national hospital discharge survey","volume":"145","author":"Stein","year":"2004","journal-title":"J Pediatr"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1182\/bloodadvances.2017013292","article-title":"Increasing rate of pulmonary embolism diagnosed in hospitalized children in the United States from 2001 to 2014","volume":"2","author":"Carpenter","year":"2018","journal-title":"Blood Adv"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1160\/TH16-07-0529","article-title":"Pulmonary embolism and in situ pulmonary artery thrombosis in paediatrics","volume":"117","author":"Rajpurkar","year":"2017","journal-title":"Thromb Haemost"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/cid\/ciy419","article-title":"Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia","volume":"68","author":"Kutty","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fmicb.2016.00023","article-title":"Classification of extrapulmonary manifestations due to Mycoplasma pneumoniae infection on the basis of possible pathogenesis","volume":"7","author":"Narita","year":"2016","journal-title":"Front Microbiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1002\/ppul.26691","article-title":"Pulmonary embolism associated with Mycoplasma pneumoniae pneumonia in children","volume":"58","author":"Chen","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12887-023-04188-7","article-title":"A retrospective study of the clinical characteristics of 9 children with pulmonary embolism associated with Mycoplasma pneumoniae pneumonia","volume":"23","author":"Song","year":"2023","journal-title":"BMC Pediatr"},{"key":"B8","first-page":"678","article-title":"Progress on Mycoplasma pneumoniae pneumonia coagulation abnormalities and related indexes in children","volume":"50","author":"Ma","year":"2023","journal-title":"Int J Pediatr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13052-023-01545-1","article-title":"Changes in coagulation markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for Mycoplasma severity","volume":"49","author":"Li","year":"2023","journal-title":"Ital J Pediatr"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.828437","article-title":"D-dimer: the risk factor of children\u2019s severe Mycoplasma Pneumoniae pneumonia","volume":"10","author":"Qiu","year":"2022","journal-title":"Front Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"100001","DOI":"10.1016\/j.rpth.2022.100001","article-title":"Direct oral anticoagulants in pediatric venous thromboembolism: experience in specialized pediatric hemostasis centers in the United States","volume":"7","author":"Corrales-Medina","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"B12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1182\/blood.2019000998","article-title":"Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children","volume":"135","author":"Brand\u00e3o","year":"2020","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/bcp.14404","article-title":"Warfarin and food, herbal or dietary supplement interactions: asystematic review","volume":"87","author":"Tan","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0027-9684(15)31045-2","article-title":"Venous thrombosis and pulmonary embolism in a child with pneumonia due to Mycoplasma pneumoniae","volume":"101","author":"Graw-Panzer","year":"2009","journal-title":"J Natl Med Assoc"},{"key":"B15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/crj.13584","article-title":"Thromboembolic complications of Mycoplasma pneumoniae pneumonia in children","volume":"17","author":"Chen","year":"2023","journal-title":"Clin Respir J"},{"key":"B16","first-page":"1482","article-title":"Mycoplasma pneumonia combined with pulmonary infarction in a child","volume":"8","author":"Zhuo","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3892\/etm.2021.9634","article-title":"Mycoplasma pneumoniae pneumonia with pulmonary embolism: a study on pediatric cases in Jilin province of China","volume":"21","author":"Sheng","year":"2021","journal-title":"Exp Ther Med"},{"key":"B18","article-title":"FDA approves drug to treat, help prevent types of blood clots in certain pediatric populations","year":""},{"key":"B19","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1055\/s-0043-1778106","article-title":"Venous thromboembolism in children: the rivaroxaban experience","volume":"50","author":"Spiezia","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"B20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.thromres.2022.11.027","article-title":"Real world experience of efficacy and safety of rivaroxaban in paediatric venous thromboembolism","volume":"221","author":"Hassan","year":"2023","journal-title":"Thromb Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e003788","DOI":"10.1161\/JAHA.116.003788","article-title":"Shorter hospital stays and lower costs for rivaroxaban compared with warfarin for venous thrombosis admissions","volume":"5","author":"Margolis","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B22","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.amjmed.2018.01.041","article-title":"Rivaroxaban versus warfarin and risk of post-thrombotic syndrome among patients with venous thromboembolism","volume":"131","author":"S\u00f8gaard","year":"2018","journal-title":"Am J Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13052-022-01344-0","article-title":"Analysis of the risk factors and clinical features of Mycoplasma pneumoniae pneumonia with embolism in children: a retrospective study","volume":"48","author":"Han","year":"2022","journal-title":"Ital J Pediatr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-022-03030-9","article-title":"Clinical characteristics of 14 pediatric mycoplasma pneumoniae pneumonia associated thrombosis: a retrospective study","volume":"23","author":"Fu","year":"2023","journal-title":"BMC Cardiovasc Disord"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1449493\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T07:28:09Z","timestamp":1739345289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1449493\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":24,"alternative-id":["10.3389\/fped.2025.1449493"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1449493","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"article-number":"1449493"}}